3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
3
Sarcoma
2
Dermatologic
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
CNS
1
Breast
1
Conditions
Multiple Myeloma
444
Lymphoma
55
Recurrence
44
Neoplasms, Plasma Cell
35
Immunoglobulin Light-chain Amyloidosis
34
Hematologic Neoplasms
34
Smoldering Multiple Myeloma
28
Lymphoma, Non-Hodgkin
26
Leukemia, Myeloid, Acute
22
Leukemia, Lymphocytic, Chronic, B-Cell
21
Neoplasms
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Hodgkin Disease
18
Myelodysplastic Syndromes
17
Monoclonal Gammopathy of Undetermined Significance
13
Leukemia
12
Waldenstrom Macroglobulinemia
11
Lymphoma, Mantle-Cell
11
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
Breast Neoplasms
11
Prostatic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
10
Paraproteinemias
9
Ovarian Neoplasms
9
Amyloidosis
9
Lung Neoplasms
8
Leukemia, Plasma Cell
8
Primary Myelofibrosis
7
Melanoma
7
Lymphoma, Follicular
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lip Neoplasms
×
Plasma cell
×
90 days
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled